"Focusing on strategies for drug repurposing and development of novel drug combinations for cancer therapeutics" 

Invited Speakers Include:

Geoffrey Bartholomeusz, Ph.D., UT M. D. Anderson Cancer Center
Jenny Chang, M.D., The Methodist Hospital Research Institute
Helen Chen, M.D., National Cancer Institute/National Institutes of Health
Kevin Dalby, Ph.D., University of Texas at Austin
Peter Davies, M.D., Ph.D., Texas A&M University System Health Science Center
Giulio Draetta, M.D., Ph.D., UT M. D. Anderson Cancer Center
Chih-Ming Ho, Ph.D., University of California at Los Angeles
Razelle Kurzrock, M.D., UT M. D. Anderson Cancer Center
J. Jack Lee, Ph.D., UT M. D. Anderson Cancer Center
Joseph Lehar, Ph.D., Novartis
Michael Mancini, Ph.D., Baylor College of Medicine
Giovanni Paternostro, M.D., Ph.D., Sanford Burnham Medical Research Institute
John Peterson, GlaxoSmithKline Pharmaceuticals 
Clifford Stephan, Ph.D, Texas A&M University System Health Science Center
Stephen Wong, Ph.D., The Methodist Hospital Research Institute
Ralph Zinner, M.D., UT M. D. Anderson Cancer Center